
Results
8
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
8 companies
Selvita
Market Cap: zł758.1m
Operates as a contract research organization worldwide.
SLV
zł41.30
7D
-5.1%
1Y
-9.2%
Ryvu Therapeutics
Market Cap: zł578.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł25.00
7D
-2.3%
1Y
14.4%
BIOTON
Market Cap: zł355.5m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.18
7D
-3.2%
1Y
18.1%
Poltreg
Market Cap: zł111.5m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł24.60
7D
-5.4%
1Y
-29.7%
Biogened
Market Cap: zł46.7m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł19.10
7D
-3.5%
1Y
-28.7%
Genomed Spólka Akcyjna
Market Cap: zł30.7m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł18.00
7D
-10.0%
1Y
-28.0%
Stem Cells Spin
Market Cap: zł15.7m
Operates as a biotechnology company in Poland.
SCS
zł0.38
7D
-2.6%
1Y
92.9%
Labocanna
Market Cap: zł4.7m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
4.8%
1Y
-35.7%